No document available.
Keywords :
Antilipemic Agents/therapeutic use; Cholesterol, HDL/blood; Cholesterol, LDL/blood; Exercise Therapy; Heart Diseases/etiology; Humans; Hypercholesterolemia/complications; Hypertriglyceridemia/complications; Hypolipoproteinemias/complications/diet therapy/drug therapy; Life Style; Niacin/therapeutic use; Risk Factors
Abstract :
[en] The decision to treat an individual with low HDL cholesterol level depends on his overall cardiovascular risk profile and the therapeutic strategy is based upon the characteristics of the lipid profile (isolated abnormality, associated hypertriglyceridaemia or combined elevation of LDL cholesterol). The treatment must favour diet and exercise, before considering a possible pharmacological approach. Results are usually acceptable with better life habits and appropriate diet when low HDL cholesterol level is associated to hypertriglyceridaemia. From a pharmacological point of view, the best results are obtained with fibrates or nicotinic acid. However, results are often disappointing when low HDL cholesterol level is isolated.
Scopus citations®
without self-citations
0